Component
Lycopene distribution into the LDL plasma fraction
Lycopene distribution into the LDL plasma fraction. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Approximately 79% ± 9% of plasma lycopene was associated with LDL in seven participants.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/lycopene-research/7562097.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a8e551bad4ddb5e7eb7d3c8d796a94532e7f4701e891d9daae92a44bfb04179b", "start_char": 0, "end_char": 1620, "text_sha256": "a8e551bad4ddb5e7eb7d3c8d796a94532e7f4701e891d9daae92a44bfb04179b"}
- experimental_model
- Plasma lipoprotein fractionation and ex-vivo incubation
- exposure
- Native plasma distributions and incubation experiments
- limitations
- Small descriptive study; distribution is not proof that raising LDL improves delivery or health.
- nutrient_topic
- Lycopene research collection; topical membership is not evidence of a direct dietary effect. · Lycopene
- organism
- Human, seven normolipidemic participants
- plain_language
- Lycopene travels with blood lipoproteins; a blood measurement also reflects its carriers.
- primary_references
- [lycopene-p7562097] Distributions of carotenoids and alpha-tocopherol among lipoproteins do not change when human plasma is incubated in vitro. (1995). https://pubmed.ncbi.nlm.nih.gov/7562097/ DOI: 10.1093/jn/125.10.2610
- tissue_or_cell_type
- Plasma LDL, HDL and VLDL
Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17) · lines 247–258
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Plasma lipoprotein fractionation and ex-vivo incubation · source_derived_draft · unverified_draft
### lycopene-ldl-carriage Approximately 79% ± 9% of plasma lycopene was associated with LDL in seven participants. Condition category: normal nutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect. plain_language: Lycopene travels with blood lipoproteins; a blood measurement also reflects its carriers. organism: Human, seven normolipidemic participants tissue_or_cell_type: Plasma LDL, HDL and VLDL experimental_model: Plasma lipoprotein fractionation and ex-vivo incubation limitations: Small descriptive study; distribution is not proof that raising LDL improves delivery or health. exposure: Native plasma distributions and incubation experiments evidence_span: {"source_cache": "artifacts/lycopene-research/7562097.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a8e551bad4ddb5e7eb7d3c8d796a94532e7f4701e891d9daae92a44bfb04179b", "start_char": 0, "end_char": 1620, "text_sha256": "a8e551bad4ddb5e7eb7d3c8d796a94532e7f4701e891d9daae92a44bfb04179b"} [lycopene-p7562097] Distributions of carotenoids and alpha-tocopherol among lipoproteins do not change when human plasma is incubated in vitro. (1995). https://pubmed.ncbi.nlm.nih.gov/7562097/ DOI: 10.1093/jn/125.10.2610
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.